Year-over-year earnings per share growth for the last twelve months: Vaccinex, Inc. (VCNX)

vaccinex.com (VCNX) - corporate logo

Management at the micro-cap biotech Vaccinex, Inc. (VCNX) is operating under strict austerity measures while constantly seeking new financing. The primary threats involve the potential failure of Huntington's disease research and a rapid cash burn rate. Profit potential is based on royalties from the development of oncology antibodies. Quarterly EPS variation demonstrates profit dynamics, where the 0.00 mark characterizes this parameter.

Vaccinex Inc. (VCNX) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 12/28/2024

Comprehensive metric breakdowns and analytics for vaccinex.com (VCNX)

- share price and expert price forecast:
Stock Price Vaccinex Inc|VCNX - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value Vaccinex, Inc.|VCNX - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share Vaccinex|VCNX - Company Net Assets|Market Cap to Net Assets Ratio vaccinex.com|VCNX - Company Total Assets
- debt and liquidity details:
Debt to Equity Vaccinex, Inc.|VCNX - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Vaccinex Inc|VCNX - Company Cumulative Debt|Debt to Book Value Vaccinex|VCNX - Long-Term Indebtedness|Company Current Liabilities Vaccinex|Quick Ratio vaccinex.com
- earnings and market multiples details:
VCNX - Final Profit|Projected Future Earnings Vaccinex, Inc.|VCNX - Market Cap to Earnings|Future Price to Earnings Vaccinex, Inc.|VCNX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Vaccinex Inc|VCNX - Operating profit EBITDA|Earnings per share for the last twelve months Vaccinex|VCNX - Earnings per one share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months vaccinex.com|VCNX - Earnings per share growth rate in current year|Expected earnings per share growth for next year Vaccinex, Inc.
- revenue and sales proceeds data:
VCNX - Company Revenue|Projected Sales Volume Vaccinex Inc.|VCNX - P/S Multiple|Forward P/S Multiple Vaccinex, Inc.
Comprehensive company analysis:Vaccinex Inc., VCNX
Manufactured product of Vaccinex, Inc.

Analyzing Vaccinex, Inc. (VCNX) through changes in quarterly EPS dynamics allows for tracking the transformation rates of net income per share, revealing hidden financial dips between 10-Q reports. For a biotech firm with the R&D potential of the pepinemab platform, this indicator measures the efficiency of capitalizing scientific developments, where earnings volatility reflects the balance between innovation costs and the market valuation of technological leadership.

Competitors of Vaccinex, Inc.

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months januxrx.com|Year-over-year net earnings per share growth for the last 12 months arcusbio.com (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc (ZYME)|Year-over-year net earnings per share growth for the last 12 months Tango Pharma TNGX|Iovance Biotherapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics Biotechnologies IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|CMPX (compasstherapeutics.com) - Year-over-year earnings per share growth for the last 12 months|Replimune Inc. (REPL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Lyell Immunopharma Inc (LYEL)|Year-over-year net earnings per share growth for the last 12 months IPHA|PYXS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months CGEN (Compugen Ltd.)|Year-over-year earnings per share growth rate for the last twelve months IOBT|Quarterly EPS earnings growth STRO (Sutro Biopharma)|Year-over-year earnings per one share growth for the last 12 months INKT|Werewolf - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Immix Biopharma|ALX Oncology (ALXO) - Year-over-year earnings per share growth for the last twelve months|cuebiopharma.com (CUE) - Quarterly EPS earnings growth|PDSB (PDS Biotechnology Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth sonnetbio.com|Year-over-year earnings per share growth for the last twelve months MAIA Biotechnology, Inc. (MAIA)|LIMN: Year-over-year net earnings per share trend for the last twelve months|LAVA Therapeutics - Year-over-year net earnings per share growth for the last 12 months|nextcure.com (NXTC) - Earnings per share growth in annualized terms for the last twelve months|LPTX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Intensity Therapeutics, Inc. INTS|SNSE: Quarterly EPS earnings growth|Synthetic Biologics - Year-over-year earnings per one share growth for the last 12 months|GRTS (Gritstone bio) - Quarterly EPS earnings growth|KA (Kineta, Inc.) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth NEXI|Turnstone Biologics Corp - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP